Pharmaceutical Executive-11-01-2008

Top Rx Club Award winners exhibit qualities that ironically juxtapose industry's paradigm (pdf)

It's been a year since consumer marketing master Joe Jimenez took over the top spot at Novartis Pharma. How's he faring?

A five-year forecast of the multiple-sclerosis market following the disruptions of Tysabri

As Congress moves to curb industry influence, support for med ed is waning

Evaluating experience: It's what you know, not how long you know it

The former health secretary offers a reality check on healthcare reform-and what to expect from the pols in '09

Is FDA's MO in foreign inspections too broken to fix?

Don't throw out sales force effectiveness with the sales force-some sure-fire strategies

Here are the hottest gadgets and gizmos to make a dent in drug noncompliance

Some say it's just another pharma facing its patent cliff. But others say this company's got it worse. With new CEO John Lechleiter in charge, can Lilly find its way back from the edge?